BMI Calculation and Classification
This 50-year-old female with a height of 5 feet (152.4 cm) and weight of 75 kg has a BMI of 32.3 kg/m², which classifies her as Class 1 (mild) obesity, and she requires weight loss treatment with an initial goal of 10% body weight reduction. 1, 2
BMI Calculation
- BMI is calculated as weight in kilograms divided by height in meters squared: 75 kg ÷ (1.524 m)² = 32.3 kg/m² 1
- This calculation can also be performed using the formula: [weight (in pounds)/height (in inches)²] × 703 1
Classification According to Current Guidelines
The patient falls into Class 1 obesity (BMI 30-34.9 kg/m²) based on the World Health Organization and American Heart Association classification systems. 3, 1, 2
The obesity classification system defines:
- Normal weight: BMI 18.5-24.9 kg/m² 3, 1
- Overweight: BMI 25-29.9 kg/m² 3, 1
- Class 1 obesity (mild): BMI 30-34.9 kg/m² 1, 2
- Class 2 obesity (moderate): BMI 35-39.9 kg/m² 2, 4
- Class 3 obesity (severe/morbid): BMI ≥40 kg/m² 2, 4
Health Risk Assessment
- Class 1 obesity is associated with increased risk for cardiovascular disease, type 2 diabetes, hypertension, dyslipidemia, sleep apnea, and certain cancers. 1, 4
- Disease risk increases significantly when BMI exceeds 25.0 kg/m², with overall mortality beginning to increase at BMI levels greater than 25 kg/m² 3
- Cardiovascular and other obesity-related disease risks increase independently with increasing BMI and excess abdominal fat 3
Recommended Management Algorithm
Based on the American College of Cardiology guidelines, weight loss treatment is recommended for this patient because her BMI is ≥30.0 kg/m², with an initial goal of 10% body weight reduction (7.5 kg). 1, 2
Additional Assessment Required
- Measure waist circumference to assess central adiposity and further stratify cardiovascular risk. 1, 2, 4
- Screen for obesity-related comorbidities including hypertension, dyslipidemia, type 2 diabetes, sleep apnea, and fatty liver disease 4
Treatment Components
High-frequency counseling (≥16 sessions in 6 months) focusing on nutrition, physical activity, and behavioral therapy is recommended. 4
- Caloric restriction to 1200-1500 kcal/day for women 4
- For women aged 51+ years, recommended daily energy allowance is approximately 1,900 kcal for light to moderate physical activity 3
- Physical activity should be incorporated as part of comprehensive lifestyle modification 1, 4
Pharmacotherapy should be considered as an adjunct to lifestyle interventions for patients with BMI ≥30 kg/m². 4
- GLP-1 receptor agonists (semaglutide, liraglutide) are particularly beneficial options 4
- Pharmacotherapy is recommended in combination with, not as a replacement for, lifestyle modifications 4
Monitoring
- During active weight management, monitor anthropometric measurements at least every 3 months 4
- Regularly assess for improvements in obesity-related comorbidities 4
- Even 3-7% weight loss improves glycemia and cardiovascular risk factors, though >10% weight loss provides greater benefits 4
Important Clinical Considerations
BMI has limitations as it does not distinguish between lean and fat mass, potentially misclassifying individuals with high muscle mass. 1, 2
- BMI has good specificity (90%) but low sensitivity (50%) for diagnosing excess adiposity 1, 2
- Waist circumference measurement provides additional information about central adiposity, which increases risk for cardiovascular and other diseases independent of overall obesity 1
- The combination of BMI and waist circumference provides more comprehensive risk assessment than BMI alone 1, 2